Insider filing · SNDX
Dennis Podlesak
Director
profile →
Syndax Pharmaceuticals, Inc.
SNDX · Healthcare · 11 filings in 24 months
ticker →
Dennis Podlesak sold $875K of Syndax Pharmaceuticals (SNDX)
Executed Aug 14 2025, disclosed Aug 18 2025, 4 days later.
Value, as filed
$875K
57,600 sh across 3 lots
Executed
Aug 14 2025
the trade date, as filed
Disclosed
Aug 18 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
DPDennis Podlesak (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Syndax Pharmaceuticals, Inc. (SNDX). The largest single filing was $114K of SNDX (8,000 sh × $14.21, as filed), executed Oct 29.
The name
SNDXHealthcare · Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Dennis Podlesak in SNDX
SNDXSALE
Syndax Pharmaceuticals, Inc.
$114K8,000 sh × $14.21
Exec Oct 29
Filed Oct 30 · 7:09 PM ET